U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H22ClFN6O2
Molecular Weight 432.8798
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PARSACLISIB

SMILES

CCOc1c(cc(c(c1[C@@]2([H])CC(=NC2)O)F)Cl)[C@]([H])(C)n3c4c(c(C)n3)c(N)ncn4

InChI

InChIKey=ZQPDJCIXJHUERQ-QWRGUYRKSA-N
InChI=1S/C20H22ClFN6O2/c1-4-30-18-12(6-13(21)17(22)16(18)11-5-14(29)24-7-11)10(3)28-20-15(9(2)27-28)19(23)25-8-26-20/h6,8,10-11H,4-5,7H2,1-3H3,(H,24,29)(H2,23,25,26)/t10-,11-/m0/s1

HIDE SMILES / InChI

Molecular Formula C20H22ClFN6O2
Molecular Weight 432.8798
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Jun 25 22:36:40 UTC 2021
Edited
by admin
on Fri Jun 25 22:36:40 UTC 2021
Record UNII
OS7097575K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PARSACLISIB
INN   USAN  
Official Name English
PARSACLISIB [USAN]
Common Name English
INCB-050465
Code English
INCB050465
Code English
PARSACLISIB [INN]
Common Name English
2-PYRROLIDINONE, 4-(3-((1S)-1-(4-AMINO-3-METHYL-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)ETHYL)-5-CHLORO-2-ETHOXY-6-FLUOROPHENYL)-, (4R)-
Systematic Name English
PARSACLISIB [WHO-DD]
Common Name English
(4R)-4-(3-((1S)-1-(4-AMINO-3-METHYL-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)ETHYL)-5-CHLORO-2-ETHOXY-6-FLUOROPHENYL)PYRROLIDIN-2-ONE
Systematic Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 707319
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
FDA ORPHAN DRUG 758420
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
FDA ORPHAN DRUG 703919
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
FDA ORPHAN DRUG 688519
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
FDA ORPHAN DRUG 707419
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
FDA ORPHAN DRUG 688319
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
Code System Code Type Description
INN
10589
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
PRIMARY
FDA UNII
OS7097575K
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
PRIMARY
NCI_THESAURUS
C113434
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
PRIMARY
CAS
1426698-88-5
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
PRIMARY
DRUG BANK
DB14867
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
PRIMARY
PUBCHEM
86677874
Created by admin on Fri Jun 25 22:36:40 UTC 2021 , Edited by admin on Fri Jun 25 22:36:40 UTC 2021
PRIMARY
Related Record Type Details
OFF TARGET->NON-INHIBITOR
IC50
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT
OFF TARGET->NON-INHIBITOR
IC50
OFF TARGET->NON-INHIBITOR
IC50
OFF TARGET->NON-INHIBITOR
IC50
Related Record Type Details
ACTIVE MOIETY